RY 172.7 -0.1792% SHOP 152.38 -3.7762% TD 74.49 -0.4144% ENB 58.66 0.2906% BN 80.21 0.2124% TRI 235.76 -0.7034% CNQ 42.27 -1.3305% CP 102.81 -2.4851% CNR 145.02 -0.9426% BMO 139.15 0.5855% BNS 77.045 -0.149% CSU 4497.2998 0.6756% CM 92.23 -0.335% MFC 43.28 0.8858% ATD 79.0 -1.1882% NGT 53.35 -1.8038% TRP 65.26 0.215% SU 49.61 -1.411% WCN 251.65 -0.2181% L 191.14 0.1205%

MustGrow Biologics Corp.

Basic Materials CA MGRO

1.2CAD
-0.04(3.23%)

Last update at 2024-12-19T17:48:00Z

Day Range

1.201.27
LowHigh

52 Week Range

0.622.53
LowHigh

Fundamentals

  • Previous Close 1.24
  • Market Cap89.85M
  • Volume10514
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM4.71M
  • Revenue Per Share TTM0.09
  • Gross Profit TTM -0.19072M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.67694M -5.56584M -3.06387M -3.30993M
Minority interest - - - -
Net income -0.67694M -5.56584M -3.06387M -3.30993M
Selling general administrative 3.68M 4.48M 2.08M 2.86M
Selling and marketing expenses - - - -
Gross profit - - - -
Reconciled depreciation - - - -
Ebit - - - -
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -0.80499M -5.68512M -3.01250M -3.36925M
Other operating expenses - - - -
Interest expense 0.00000M 0.01M 0.05M 0.05M
Tax provision - - - -
Interest income 0.21M 0.10M 0.00332M -
Net interest income 0.21M 0.09M -0.04944M -0.04587M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue 4.71M 0.00648M 0.01M 0.00000M
Total operating expenses 5.52M 5.69M 3.03M 3.37M
Cost of revenue - - - -
Total other income expense net -0.08355M 0.03M -0.00193M 0.11M
Discontinued operations - - - -
Net income from continuing ops -0.67694M -5.56584M -3.06387M -3.30993M
Net income applicable to common shares - - - -
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 6.94M 7.13M 9.70M 3.37M -
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 1.35M 1.90M 1.25M 1.05M -
Total stockholder equity 5.58M 5.24M 8.46M 2.32M -
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - - - - -
Capital stock 25.06M 24.03M 23.03M 14.14M -
Retained earnings -23.28102M -22.60408M -17.03824M -13.97436M -
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 6.82M 7.02M 9.62M 3.31M -
Cash and equivalents - - - - -
Total current liabilities 1.21M 1.54M 0.86M 0.35M -
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt 0.62M 0.40M 0.37M 0.21M -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - - -
Total current assets 6.94M 7.13M 9.70M 3.37M -
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables - - - - -
Long term debt 0.14M 0.36M 0.38M 0.70M -
Inventory - - - - -
Accounts payable - - - 0.14M 0.10M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M 0.00000M 0.00000M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities 0.10M 0.65M 8.72M 1.86M -
Change to operating activities - - - - -
Net income -0.67694M -5.56584M -3.06387M -3.30993M -
Change in cash -0.19901M -2.60379M 6.31M -0.71602M -
Begin period cash flow 7.02M 9.62M 3.31M 4.03M -
End period cash flow 6.82M 7.02M 9.62M 3.31M 4.03M
Total cash from operating activities -0.29476M -3.25754M -2.41178M -2.57882M -
Issuance of capital stock - 0.00000M 6.59M 0.00000M 4.81M
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - 0.00000M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.54424M 0.60M 0.33M 0.01M -
Stock based compensation 0.93M 1.69M 0.27M 0.78M -
Other non cash items - 0.01M 0.05M 0.05M 0.05M
Free cash flow -0.29476M -3.25754M -2.41178M -2.57882M -

Peer Comparison

Sector: Basic Materials Industry: Agricultural Inputs

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MGRO
MustGrow Biologics Corp.
-0.04 3.23% 1.20 - - 19.07 23.98 18.19 -10.1193
IFOS
Itafos Corp
- -% 1.73 25.57 5.90 0.73 0.77 0.59 4.28
EAC
Earth Alive Clean Technologies Inc
- -% 0.005 - - 0.90 0.52 0.45 0.28
GROW
CO2 Gro Inc
- -% 0.02 - - 13.29 22.55 12.47 -3.8637

Reports Covered

Stock Research & News

Profile

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

MustGrow Biologics Corp.

1005 ? 201 1st Avenue South, Saskatoon, SK, Canada, S7K 1J5

Key Executives

Name Title Year Born
Mr. Corey J. Giasson B.Sc., MBA Pres, CEO & Director 1978
Mr. Todd L. Lahti CA, CFA CFO & Corp. Sec. 1966
Mr. Colin Bletsky COO & Director NA
Mr. Corey J. Giasson B.Sc., MBA President, CEO & Director 1978
Mr. Todd L. Lahti CA, CFA CFO & Corporate Secretary 1966

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.